期刊
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
卷 70, 期 1, 页码 150-153出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.diagmicrobio.2010.12.008
关键词
ESBL; Escherichia coli; Klebsiella pneumoniae; Bacteremia; Carbapenem
For 244 patients with bacteremia due to extended-spectrum beta-lactamase (ESBL) producing Escherichia coli or Klebsiella pneumoniae treated by ertapenem (73, 29.9%) or either imipenem or meropenem (171, 70.1%), the therapeutic efficacy was evaluated. Ertapenem therapy was effective for patients with ESBL-producing E. coli or K. pneumoniae bacteremia in terms of mortality and microbiological responses, as compared with imipenem or meropenem. (C) 2011 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据